Healthcare Locums Plc shares suspended
Healthcare Locums Plc has announced that the ordinary shares of the Company have been suspended from trading on AIM with immediate effect.
The Board has strong reason to believe that the financial performance of HCL for the year to 31 December 2010 will be materially below market expectations. Serious accounting irregularities have been brought to the attention of the Board as a result of which the Company will be carrying out an immediate investigation to consider the financial implications.
The Company also announces that both Executive Vice Chairman, Kate Bleasdale and Chief Financial Officer, Diane Jarvis have been suspended pending the outcome of the investigation.
A further announcement will be made in due course.
Kate Bleasdale strongly refuted the suggestions made by the company. I am shocked and disappointed by the Boards decision. I have done nothing wrong and have always acted in the very best interests of the business and its shareholders. I will cooperate fully with any investigation and look forward to being reinstated in the very near future, Ms Bleasdale said in a statement to Recruitment International.